Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveilla

NCT07503717 is registered in ClinicalTrials.gov with Royal College of Surgeons, Ireland as lead sponsor.

NCT NCT07503717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveilla
Lead sponsor
Royal College of Surgeons, Ireland
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
June 1, 2028
Enrollment
69 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, her2-positive metastatic breast cancer